Naples Community Blood Center Adopts Mediware Blood Center Technology to Streamline Collections for Area Hospitals

LENEXA, KS--(Marketwire - August 14, 2009) - Mediware
Information Systems, Inc. (NASDAQ: MEDW) announced today that the
Naples Community Blood Center has licensed the latest version of
LifeTrak®, Mediware's market leading Donor Management System, as part of
a technology transformation at the hospital owned blood center. The
transformation effort is expected to include other core systems as the
blood center streamlines technology to improve donor recruitment
efficiencies and patient safety.

Naples Community Blood Center is part
of the Naples Community Hospital Healthcare System (NCH), an integrated
delivery network that includes two hospitals. Combined NCH received 22
awards for quality from Health
Grades in 2009 and is recognized as one of the most prestigious health
systems in the Southeast. The NCH Community Blood Center also supplies two
area HMA hospitals.

"As our hospitals transitioned to new software, we realized that our blood
center would have to update our own technologies to stay current with
modern efficiencies and safety practices," said Sheila Phillips, the
administrative director for Naples Community Blood Center. "This forced us
to do a detailed analysis of our needs and wants. We also took the
opportunity to define what we needed to improve upon in our own operation
and looked for software that would support our growth and continued
improvement."

As a part of the process, Naples staff recognized that in addition to rich
clinical capabilities, they needed to focus on donor recruitment and the
overall management of donor information; two areas in which Mediware
excels.

The Mediware blood center technology strategy includes powerful clinical
systems in combination with rich CRM donor recruitment capabilities to
streamline blood drives, increase donor recruitment, and facilitate donor
retention.

"Our objectives for our new systems platform include some lofty goals that
we are confident Mediware will help us achieve," continued Ms. Phillips.
"Obviously, we also needed to maintain our standard of quality. Our lab
team was very pleased with Mediware's system functions around quarantines,
manufacturing, labeling, and look back.

"Operationally we also wanted to build into our new platform the ability to
develop, monitor and maintain multiple donor frequency campaigns; add
electronic communication capabilities to enable us to reach out to our
donors; and the ability to reach out to specific groups with targeted
campaigns and communications. These are all key differentiators of the
Mediware approach."

A further differentiator for the Mediware products is that they are offered
in a hosted environment. "This allows us to focus on our primary business
and not worry about IT issues," concluded Ms. Phillips.

"We are thrilled to add Naples to our growing list of blood center
customers and are excited that they have chosen our latest technologies,"
said Thomas Mann, Mediware's president and chief executive officer. "This
is a segment of our business that continues to grow and we are honored that
more than 60 percent of the US blood supply is recruited, tested,
distributed or transfused using Mediware blood management products."

LifeTrak is a 510(k) cleared donor management system that manages donor
eligibility, manufacturing and distribution for many of the largest blood
suppliers, testing facilities, centralized transfusion services (CTS) and
large hospital donor programs. In the spring of 2009 Mediware launched
LifeTrak 4.0 to deliver increased flexibility through a web-based
deployment.

Mediware's Blood Center Technologies
group provides blood centers the first integrated solution offering that
spans from donor recruitment to distribution. As web-based products,
Mediware BCT solutions can be licensed individually or as an integrated
platform. In addition to the LifeTrak suite, Mediware's blood center
technologies include:

-- OrderTrakT, Enables online ordering of blood products for
hospitals;
-- CoordinatorTrakT, Motivates drive coordinators with tools that save
time and build loyalty;
-- QualityTrakT, Captures donor satisfaction statistics to enhance
customer service;
-- CallTrakT, Improves the efficiency and effectiveness of
tele-recruitment programs;
-- SalesTrakT, Maximizes sales prospects through comprehensive
customer and pipeline management; and
-- DriveTrakT, Manages mobile drive recruitment including staff
scheduling.

Mediware's blood center customer base includes more than 350 facilities,
including many of the largest independent blood centers in the United
States as well as the American Red Cross.

About Naples Community Blood Center

The NCH Community Blood Center has been serving Collier County for
approximately sixty years. The Community Blood Center was initially
developed to serve the needs of the first hospital in Collier County, the
Naples Community Hospital. It has since expanded its operations to serve
the needs of each subsequent hospital that has offered healthcare services
in the county.

About Mediware

Mediware delivers blood and medication management software systems that
encapsulate information supporting patient therapies, reinforce patient
safety practices and improve efficiencies to lower costs. Mediware's
customers include prestigious hospitals, clinics, correctional
institutions, blood centers and other public and private health care
institutions throughout the world. For more information about Mediware
products and services, visit www.mediware.com.

Certain statements in this press release may constitute "forward-looking"
statements within the meaning of the Private Securities Litigation Reform
Act of 1995, as the same may be amended from time to time (the "Act") and
in releases made by the SEC from time to time. Such forward-looking
statements are not based on historical facts and involve known and unknown
risks, uncertainties and other factors disclosed in the Company's Annual
Report on Form 10-K for the year ended June 30, 2008, which may cause the
actual results of the Company to be materially different from any future
results expressed or implied by such forward-looking statements. The
Company disclaims any obligation to update its forward-looking statements.